NILE is a Hyderabad based multi division company.It is in the field of Glass lined equipments,Pressure vessels and lead and lead alloys. In glass lined equipments sector company is competing with GMM Pfaudler and recently escaped from a hostile takeover attempt by GMM. Major chemical and pharma companies including Cydus,Cipla,Aarti,Atul ..etc are company’s customers in this segment. Now company is paying much attention to lead and lead alloy segment and commissioned a new plant at Thirupathi in last qtr. NILE is making lead through recycling method and Amar Raja Battery is the major customer of NILE in this segment. Now company is going to start commercial production in its new lead plant in Republic of Georgia which is a joint venture with a local company.
It has an equity capital of just 3 crore and promoters are holding 46 %. Recently main promoter is actively buying from open market to increase his stake. Due to sharp crash in lead prices company has posted a loss of 2.2 crore in FY 08-09,where it posted 6.5 crore profit in 07-08.Now lead prices improved sharply and due to this company posted an EPS of Rs.10/- in December qtr. Adding the small loss posted in first qtr company posted 9 month EPS of 14.47 and expected to continue good performance in last qtr too .Considering the company’s recent capacity addition and improvement in the price of it products due to the recovery in global economy, it is expected to post excellent results ahead and post an EPS around Rs.25/- for the full year .
Recently, in a verdict to settle the legal dispute between GMM Pfaudler, Andra Pradesh high court directed GMM to sell all the acquired shares of NILE (as part of its takeover attempt) in open market within a period of 48 months. Watching the counter of NILE, it is evident that someone is trying to keep the share price at lower level. This may be an attempt by the management of NILE to buy the shares at lower level when GMM started selling in the market Keep an eye on the bulk deal data and quarterly share holding pattern to enter into the scrip at appropriate time.Currently it is quoting around Rs.115/-
Disclaimer: This Blog,its owner,creator & contributor is neither a Research Analyst nor an Investment Advisor and expressing opinion only as an Investor in Indian equities. He/She is not responsible for any loss arising out of any information, post or opinion appearing on this blog.Investors are advised to do own due diligence and/or consult financial consultant before acting on any such information. Author of this blog not providing any paid service and not sending bulk mails/SMS to anyone.
Sunday, March 7, 2010
Subscribe to:
Post Comments
(
Atom
)
No comments :
Post a Comment